0001209191-19-015814.txt : 20190304
0001209191-19-015814.hdr.sgml : 20190304
20190304173105
ACCESSION NUMBER: 0001209191-19-015814
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190228
FILED AS OF DATE: 20190304
DATE AS OF CHANGE: 20190304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Palczuk Linda
CENTRAL INDEX KEY: 0001717580
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38529
FILM NUMBER: 19655376
MAIL ADDRESS:
STREET 1: 7015 ALBERT EINSTEIN DRIVE
CITY: COLUMBIA
STATE: MD
ZIP: 21046
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verrica Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001660334
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 463137900
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10 NORTH HIGH STREET
STREET 2: SUITE 200
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
BUSINESS PHONE: 484-453-3300
MAIL ADDRESS:
STREET 1: 10 NORTH HIGH STREET
STREET 2: SUITE 200
CITY: WEST CHESTER
STATE: PA
ZIP: 19380
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-28
0
0001660334
Verrica Pharmaceuticals Inc.
VRCA
0001717580
Palczuk Linda
C/O VERRICA PHARMACEUTICALS INC.
10 NORTH HIGH STREET, SUITE 200
WEST CHESTER
PA
19380
0
1
0
0
Chief Operating Officer
Employee Stock Option (Right to Buy)
11.32
2019-02-28
4
A
0
68260
0.00
A
2029-02-27
Common Stock
68260
68260
D
25% of shares subject to the option shall vest on February 28, 2020 (the "Initial Vesting Date"), and 1/48th of the shares subject to the Option shall vest each month thereafter on the same day of the month as the Initial Vesting Date, subject to the Reporting Person continuing to be a service provider through each such date.
/s/ Mark Ballantyne, Attorney-in-Fact
2019-03-04